Literature DB >> 11440418

Coma secondary to aciclovir neurotoxicity.

J Loughrey1, P Coleman, J Donohue, B Marsh.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440418     DOI: 10.1007/BF03167726

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   2.089


× No keyword cloud information.
  12 in total

Review 1.  Acyclovir: a decade later.

Authors:  R J Whitley; J W Gnann
Journal:  N Engl J Med       Date:  1992-09-10       Impact factor: 91.245

2.  Psychiatric side-effects with acyclovir.

Authors:  P Bataille; P Devos; J L Noel; C Dautrevaux; F Lokiec
Journal:  Lancet       Date:  1985-09-28       Impact factor: 79.321

Review 3.  Pharmacodynamics in the elderly.

Authors:  S H Jackson
Journal:  J R Soc Med       Date:  1994       Impact factor: 5.344

4.  Adverse effects of high-dose intravenous acyclovir in ambulatory patients with acute herpes zoster.

Authors:  B Bean; D Aeppli
Journal:  J Infect Dis       Date:  1985-02       Impact factor: 5.226

5.  Effect of renal failure on the pharmacokinetics of acyclovir.

Authors:  O L Laskin; J A Longstreth; A Whelton; H C Krasny; R E Keeney; L Rocco; P S Lietman
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

Review 6.  Acyclovir- and ganciclovir-induced neurotoxicity.

Authors:  M E Ernst; R J Franey
Journal:  Ann Pharmacother       Date:  1998-01       Impact factor: 3.154

7.  Acyclovir induced coma in the intensive care unit.

Authors:  G R Rajan; J P Cobb; C K Reiss
Journal:  Anaesth Intensive Care       Date:  2000-06       Impact factor: 1.669

Review 8.  Acyclovir-induced neurotoxicity: concentration-side effect relationship in acyclovir overdose.

Authors:  W E Haefeli; R A Schoenenberger; P Weiss; R F Ritz
Journal:  Am J Med       Date:  1993-02       Impact factor: 4.965

9.  Famciclovir, a new oral antiherpes drug: results of the first controlled clinical study demonstrating its efficacy and safety in the treatment of uncomplicated herpes zoster in immunocompetent patients.

Authors:  H Degreef
Journal:  Int J Antimicrob Agents       Date:  1994       Impact factor: 5.283

10.  Pharmacokinetics of acyclovir in humans following intravenous administration. A model for the development of parenteral antivirals.

Authors:  R J Whitley; M R Blum; N Barton; P de Miranda
Journal:  Am J Med       Date:  1982-07-20       Impact factor: 4.965

View more
  1 in total

1.  Herpes zoster encephalopathy or acyclovir neurotoxicity: a management dilemma.

Authors:  Daniel Sacchetti; Aydah Alawadhi; Mustafa Albakour; Alwyn Rapose
Journal:  BMJ Case Rep       Date:  2014-04-28
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.